Spyre Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Spyre Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
  • Spyre Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$13.6M, a 37.4% increase year-over-year.
  • Spyre Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$21.6M, a 72.6% increase year-over-year.
  • Spyre Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$96.5M, a 11728% decline from 2022.
  • Spyre Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $830K.
  • Spyre Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$11K, a 102% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$96.5M -$97.3M -11728% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-11-18
2022 $830K +$841K Jan 1, 2022 Dec 31, 2022 10-K/A 2024-11-18
2021 -$11K -$599K -102% Jan 1, 2021 Dec 31, 2021 10-K/A 2024-11-18
2020 $588K -$1.49M -71.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $2.08M +$965K +86.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $1.12M +$675K +153% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 $440K +$232K +112% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $208K +$188K +940% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 $20K +$1.46M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 -$1.44M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.